Sunday, August 25, 2019

The dangerous cocktail of substandard drugs and poor regulatory oversight in India

The dangerous cocktail of substandard drugs and poor regulatory oversight in India WHO estimates that one in ten medical products in low-and-middle-income countries is substandard or falsified. This includes India

from Moneycontrol Business News https://ift.tt/2ZA6pch

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...